跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEFAZOLIN-AFT POWDER FOR INJECTION 500MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
CEFAZOLIN-AFT POWDER FOR INJECTION 500MG/VIAL
Approved
THERAPEUTIC
CEFAZOLIN-AFT POWDER FOR INJECTION 500MG/VIAL
QILU PHARMACEUTICALS CO. LTD (CHINA)
🇸🇬 Health Sciences Authority
Approval Date
May 25, 2016
Approval ID
fd858d89194a8997
Company
QILU PHARMACEUTICALS CO. LTD (CHINA)
Type
Therapeutic
Approval Details
Approval Id
fd858d89194a8997
Drug Name
CEFAZOLIN-AFT POWDER FOR INJECTION 500MG/VIAL
Product Name
CEFAZOLIN-AFT POWDER FOR INJECTION 500MG/VIAL
Approval Number
SIN15018P
Approval Date
2016-05-25
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS, INTRAMUSCULAR
Atc Code
J01DB04
Atc Item Name
cefazolin
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Active Ingredients
CEFAZOLIN SODIUM 524MG EQV TO CEFAZOLIN BASE
500MG
CEFAZOLIN SODIUM 524 MG EQV TO CEFAZOLIN BASE
500 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 25, 2016
Approval ID
fd858d89194a8997
Type
Therapeutic
Back to HSA Approvals
